|
amphiphile
A surfactant molecule possessing both hydrophilic and lipophilic properties.
|
|
|
adrenergic antagonist
An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
EC 3.1.1.8 (cholinesterase) inhibitor
An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of cholinesterase (EC 3.1.1.8).
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Ca2+-transporting ATPase (EC 3.6.3.8).
|
|
|
local anaesthetic
Any member of a group of drugs that reversibly inhibit the propagation of signals along nerves. Wide variations in potency, stability, toxicity, water-solubility and duration of action determine the route used for administration, e.g. topical, intravenous, epidural or spinal block.
adrenergic antagonist
An agent that binds to but does not activate adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists.
|
|
|
rac-1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride—water (1/1)
|
rac- 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride—water (1/1)
|
|
(+/-)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride, monohydrate
|
ChemIDplus
|
|
1-butyl-2',6'-pipecoloxylidide monohydrochloride monohydrate
|
ChEBI
|
|
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride hydrate
|
ChEBI
|
|
bupivacaine hydrochloride
|
ChemIDplus
|
|
bupivacaine hydrochloride monohydrate
|
ChEBI
|
|
bupivacaine monohydrochloride monohydrate
|
ChEBI
|
